Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Shares Outstanding (Diluted Average) (2021 - 2022)

Catheter Precision (VTAK) has disclosed Shares Outstanding (Diluted Average) for 2 consecutive years, with $1.0 million as the latest value for Q4 2022.

  • Quarterly Shares Outstanding (Diluted Average) rose 923.76% to $1.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2022, up 923.76% year-over-year, with the annual reading at $1.0 million for FY2022, 923.76% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2022 was $1.0 million at Catheter Precision, up from $1092.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $1.0 million in Q4 2022, with the low at $128.0 in Q3 2021.